The FDA said it had enough data to confirm adequate availability of tirzepatide, effectively ending the exemption for compounded versions of the drug
Partnership activity across the obesity therapeutics market is increasingly driven by three factors: Manufacturing capacity for large-scale GLP-1 production Pipeline expansion through licensing and acquisitions New distribution models through digital health platforms Compounded GLP-1 prescriptions have attracted increased regulatory scrutiny in several markets as demand for obesity treatments continues to outpace supply
If gastrointestinal side effects occur, clinicians may delay dose escalation or step down to a previously tolerated dose
Glutathione is a naturally occurring compound found in the body and is commonly included in beauty and wellness supplements
Switching to coffee with meals, adding plant-based milk or a small amount of protein, or reducing caffeine intake often resolves the issue within days
As a natural component of human plasma, GHK-Cu has an intrinsic advantage in terms of biocompatibility
